A. V. Esch

Cancer Therapy : Preclinical In fl uence of Human OATP 1 B 1 , OATP 1 B 3 , and OATP 1 A 2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice

A. Schinkel, E. Wagenaar, E. Steeg, 2013 .

Impact of ABC transporters on the disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine) and its mutagenic metabolites in vivo

H. Rosing, J. Beijnen, A. Schinkel, 2009 .

Cancer Therapy : Preclinical High Impact of Oatp 1 a / 1 b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

A. Schinkel, E. Wagenaar, E. Steeg, 2011 .

Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)

J. Beijnen, A. Schinkel, S. Durmuş, 2014, Pharmaceutical Research.

Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)

J. Beijnen, A. Schinkel, S. Durmuş, 2014, Pharmaceutical Research.

Impact of Abcc2 (Mrp2), Abcc3 (Mrp3) and Abcg2 (Bcrp1) on the oral pharmacokinetics of the anti- cancer drug methotrexate and its main metabolite 7- hydroxymethotrexate in mice

A. Schinkel, E. Wagenaar, O. Tellingen, 2009 .